According to Gilead Sciences's latest financial reports the company's total debt is $24.98 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $24.98 B | -0.96% |
2022-12-31 | $25.23 B | -5.49% |
2021-12-31 | $26.69 B | -14.99% |
2020-12-31 | $31.40 B | 27.69% |
2019-12-31 | $24.59 B | -9.99% |
2018-12-31 | $27.32 B | -18.54% |
2017-12-31 | $33.54 B | 27.31% |
2016-12-31 | $26.34 B | 19.46% |
2015-12-31 | $22.05 B | 77.81% |
2014-12-31 | $12.40 B | 86.92% |
2013-12-31 | $6.63 B | -19.31% |
2012-12-31 | $8.22 B | 8.11% |
2011-12-31 | $7.60 B | 118.29% |
2010-12-31 | $3.48 B | 179.15% |
2009-12-31 | $1.24 B | 7.6% |
2008-12-31 | $1.16 B | -11.56% |
2007-12-31 | $1.31 B | -7% |
2006-12-31 | $1.41 B | 368.86% |
2005-12-31 | $0.30 B | 72395.42% |
2004-12-31 | $0.41 M | -99.88% |
2003-12-31 | $0.34 B | -41.98% |
2002-12-31 | $0.59 B | 136.41% |
2001-12-31 | $0.25 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 17.39% | ๐บ๐ธ USA |
Pfizer PFE | $70.84 B | 183.53% | ๐บ๐ธ USA |
AbbVie ABBV | $59.38 B | 137.66% | ๐บ๐ธ USA |
Eli Lilly LLY | $25.22 B | 0.95% | ๐บ๐ธ USA |
Amgen AMGN | $64.61 B | 158.59% | ๐บ๐ธ USA |
Biogen BIIB | $7.33 B | -70.63% | ๐บ๐ธ USA |
Illumina ILMN | $2.26 B | -90.95% | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | $0.80 B | -96.76% | ๐บ๐ธ USA |
Merck MRK | $35.05 B | 40.29% | ๐บ๐ธ USA |